Cited by 213Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2024

Open access
American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., Aleppo, Grazia, Bannuru, Raveendhara R., Bruemmer, Dennis, Collins, Billy S., Ekhlaspour, Laya, Hilliard, Marisa E. +15 more·2024·Diabetes Care

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc24-s008

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-dose liraglutide (3 mg daily subcutaneously) is approved as an adjunctive medication for weight loss in adults with obesity or overweight-related comorbidities and for treatment of obese children and adolescents aged 12 years or older.

    “The GLP-1 receptor agonist liraglutide at a high dose (administered as a single daily injection of 3 mg subcutaneously) has been approved as an adjunctive medication for weight loss achieved through a low-calorie diet and physical activity in adults with obesity or overweight-related comorbidities, as well as for the treatment of obese children and adolescents aged 12 years or older [70].”

    From New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists (2024) · cites this paper as [70]

    The Approved Obesity Pharmacotherapy section describes FDA-approved weight-management medications as adjuncts to reduced-calorie diet and increased physical activity for adults with obesity or overweight-related comorbidities, and identifies liraglutide among them. Table 8.1 lists liraglutide at 3 mg daily, but this paper does not state that it is approved for children or adolescents aged 12 or older; it directs readers to a different section for adolescent approvals. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Current clinical guidelines recommend a reduction in total body weight of approximately 3-7% to achieve improvements in metabolic parameters, including glycemic control and cardiovascular risk.

    “Regarding adiposity, current clinical guidelines recommend a reduction in total body weight of approximately 3–7% to achieve improvements in metabolic parameters, including glycemic control and cardiovascular risk [196–198].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Kushner, R. F., Lingvay, I., Matfin, G., McCoy, R. G., Perry, M. L., Pilla, S. J., Polsky, S., Prahalad, P., Pratley, R. E., Segal, A. R., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
Venue
Diabetes Care
Published
2023-12-11
Volume
47
Issue
Supplement_1
Pages
S145-S157
ISSN
0149-5992 (ISSN-L)
OpenAlex
W4389560512
Cited by
213
References
143
Citations by year
2026: 51 · 2025: 97 · 2024: 65
FWCI
7.66
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK121942)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Keywords
obesity, weight management, type 2 diabetes, diabetes prevention, diabetes treatment, clinical guidelines, American Diabetes Association standards of care
MeSH terms
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrinology, Humans, Obesity, Reference Standards, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review